Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Kazia
Sort By
Newest First
1 / 1
Phase I
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
Kazia Therapeutics Limited
PR-M04-19-NI-022
Apr 05, 2019
Orphan Drug
Kazia Receives FDA Orphan Designation for GDC-0084
Kazia Therapeutics Limited
PR-M02-18-NI-107
Feb 28, 2018
1 / 1
